Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$56.67 - $69.36 $20.5 Million - $25 Million
-361,051 Reduced 87.25%
52,776 $3.64 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $684,258 - $883,383
13,857 Added 3.46%
413,827 $25.8 Million
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $8.27 Million - $10.6 Million
170,068 Added 73.97%
399,970 $22.4 Million
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $5.27 Million - $6.62 Million
109,890 Added 91.57%
229,902 $11.6 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $195,935 - $250,841
3,725 Added 3.2%
120,012 $6.55 Million
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $242,290 - $311,608
-4,068 Reduced 3.38%
116,287 $7.27 Million
Q3 2022

Nov 14, 2022

SELL
$57.96 - $78.12 $3.64 Million - $4.9 Million
-62,784 Reduced 34.28%
120,355 $8.48 Million
Q2 2022

Aug 10, 2022

SELL
$39.5 - $64.42 $2.57 Million - $4.19 Million
-65,039 Reduced 26.21%
183,139 $10.4 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $1.77 Million - $2.55 Million
40,563 Added 19.54%
248,178 $15.5 Million
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $1.14 Million - $1.67 Million
22,766 Added 12.32%
207,615 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $1.84 Million - $2.44 Million
30,997 Added 20.15%
184,849 $12 Million
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $4.52 Million - $5.88 Million
87,906 Added 133.3%
153,852 $9.76 Million
Q1 2021

May 14, 2021

SELL
$49.14 - $59.89 $317,296 - $386,709
-6,457 Reduced 8.92%
65,946 $3.95 Million
Q4 2020

Feb 12, 2021

SELL
$42.19 - $51.5 $2.15 Million - $2.63 Million
-51,050 Reduced 41.35%
72,403 $3.61 Million
Q3 2020

Nov 16, 2020

SELL
$35.33 - $51.04 $1.39 Million - $2 Million
-39,274 Reduced 24.13%
123,453 $6.3 Million
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $310,728 - $540,214
13,563 Added 9.09%
162,727 $5.71 Million
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $630,621 - $1.45 Million
-38,359 Reduced 20.46%
149,164 $3.79 Million
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $3.67 Million - $5.43 Million
187,523 New
187,523 $5.2 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.